Aeovian Pharmaceuticals is a biopharmaceutical company specializing in therapeutics for the treatment of rare and age-related diseases. It develops selective modulators of the mTORC1 pathway with the potential to address multiple underlying causes of disease initiation and progression, such as oxidative, cellular, and environmental stress.